StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ZEPP$12.21+0.00%
Fair $54.92+349.8%

ZEPP

Zepp Health Corporation

Technology / Consumer ElectronicsNYSE

$12.21

+0.00 (+0.00%)

Significantly Undervalued+349.8%Fair Value $54.92Fund rank 23/100 · Data gapSEC 11/11 yrs|
SA 11/F
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 28% · confianza 25%

FCF escenarios

weak_data · normalized FCF $-25.8M · quality 32.0/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 15/100Data QA 35/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

11/100

F

Piotroski

4/9

balance/quality

Valuation

100/100

+349.8% upside

5Y CAGR

+53.3%

100/100

Data QA

100/100

SEC 100%

Latest source: sec-companyfactsPeriods: 11Warnings: 1sec-companyfacts: 11
ROE is -18.7%, below the 5% threshold
Thesis & Journal · ZEPPLocal privado en este navegador · Zepp Health Corporation
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$179M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-18.7%

↓

Gross Margin

38.3%

↑

Debt/Equity

N/A

•
No hay histórico de precio usable para pintar el gráfico TradingView.

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2015–2025 · 10 años de histórico normalizado

Revenue CAGR

-11.7%

FCF CAGR

—

FCF margin

-10.1%

FCF / Net income

0.65x

Latest source

SEC-backed

Margin decomposition

Último año: revenue $258.9M · net income $-40.1M · FCF $-26.2M

2015-FY → 2025-FY

Gross margin

38.3%+26.0% pts

Operating margin

-11.3%-6.8% pts

Net margin

-15.5%-11.3% pts

FCF margin

-10.1%-9.0% pts
SEC-backed annual metrics active for 2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015. Local SEC Companyfacts override Yahoo/FMP for audited annual line items; provider-only fields remain as fallback.
MetricTTM
2025SEC
2024SEC
2023SEC
2022SEC
2021SEC
2020SEC
2019SEC
2018SEC
2017SEC
2016SEC
2015SEC
Income Statement
Revenue$258.9M$258.9M$182.6M$352.9M$613.6M$980.8M$986.0M$834.9M$530.2M$2.05B$1.56B$896.5M
Net Income$-40.1M$-40.1M$-75.7M$-31.0M$-43.2M$21.6M$35.1M$82.6M$49.5M$25.8M$23.9M$-37.9M
EPS-0.16-0.16-0.29-0.13-0.180.080.130.320.070.10-0.22-1.22
Gross Margin38.3%38.3%38.5%26.2%19.4%20.9%20.7%25.3%25.8%3.7%17.7%12.3%
Operating Margin-11.3%-11.3%-25.9%-8.6%-10.1%1.5%2.7%10.4%10.0%1.4%0.9%-4.5%
Net Margin-15.5%-15.5%-41.5%-8.8%-7.0%2.2%3.6%9.9%9.3%1.3%1.5%-4.2%
Cash Flow
Free Cash Flow$-26.2M$-26.2M$-25.8M$41.0M$-118.3M$-43.7M$11.3M$56.6M$100.4M$33.3M$7.0M$-9.7M
Returns
ROE-18.7%-18.7%-30.1%-8.8%-11.2%4.7%8.4%23.0%18.8%74.3%79.3%-180.1%
Valuation
P/E—————152.6393.9238.16174.43122.10——
P/B14.4814.4812.568.467.767.047.608.7010.4326.8422.50—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total n/d
Return attribution requires positive start and end prices.

Unavailable: positive start/end prices are required.